This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Avista Capital Partners has announced it has acquired Terrats Medical from Miura Partners. Terrats, based in Barcelona, Spain, is a provider of dental prosthetics. The company sells into more than 50 countries. By: McGuireWoods LLP
Gainline Capital Partners has announced its acquisition of M&M International. M&M, founded in 1993 and based in South Plainfield, New Jersey, manufactures stainless steel tubing primarily for medical devices. By: McGuireWoods LLP
New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device markets and aerospace industries. billion, according to industry reports. ILC, founded in 1947 and based in Frederica, Del., By: McGuireWoods LLP
In the pursuit of attractive equity returns, privateequity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of privateequity-backed roll-up activity.
When you hear the words “healthcare privateequity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—privateequity firms have a lot of capital to put to work. ENT and allergy is relatively new to privateequity investment, with approximately ten major platforms currently operating.
Compared to other medical fields like dentistry and dermatology, privateequity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.
For top privateequity firms, there’s a lot to like about SaaS. Top Software PrivateEquity Firms Here is a select list of the most active PE investors in the SaaS and software industry over the past year (data taken from the SEG 2024 Annual SaaS Report ).
We are seeing an increasing amount of privateequity entering the veterinary space, both at the clinic level and the pet product level. Privateequity is already investing heavily in the pet industry, and it is expected to continue to grow. Without the human capital, a business would not be able to function.
The 6th annual Midwest M&A/PrivateEquity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.
This article focuses on how medical practices are valued by privateequity-backed groups, and to an extent, health systems and other strategic acquirers. Physician practices are almost always valued on a multiple of EBITDA basis in transactions with privateequity groups or similar buyers.
Healthcare-focused growth equity firm River Cities Capital Funds , or RC Capital , has linked up with James River Cardiology and formed Aligned Cardiovascular Partners. and Cincinnati-based RC Capital tapped McDermott Will & Emery LLP for legal advice. RC Capital, which has offices in Cincinnati and Raleigh, N.C.,
3 spot on The Deal’s privateequity league table for law firms. The combination with Waller gave Holland & Knight increased capabilities in healthcare, well as in privateequity, financial services, real estate and litigation. As of March, the merged entity had nearly 2,000 attorneys in 34 offices in the U.S.
Two-thirds of the UK’s fintech start-ups are in in the city, and in 2020, the capital attracted 94 per cent of the country’s total fintech venture capital. Beringea Beringea is a transatlantic venture capital firm with more than $800m under management across its funds in the UK and the US.
continues their goal of acquiring and integrating leading medical aesthetics clinics, enabling medical professionals in their subsidiaries to achieve personal and professional goals while creating world-class customer experiences by networking support, collaboration, and community.
Update on PrivateEquity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. These firms remain “on the clock” to deploy their capital.
Summary Privateequity-backed Physician Practice Management (“PPM”) companies in the ENT & Allergy space continued a conservative growth trajectory during Q1 2024. Introduction Privateequity groups began investing in the ear, nose, and throat and allergy space in 2018.
On April 23 a group led by privateequity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 While the biggest recent deal, OneOncology is hardly the first oncology platform to be sold to a privateequity group.
Excolere Equity Partners is a leading middle market privateequity firm that leverages its deep sector experience and strategic and operational expertise to accelerate the growth and enhance the impact of companies in the Education and Human Capital sector. ISP Schools is a portfolio company of OMERS PrivateEquity.
Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., based privateequity investor that specializes in acquiring software businesses in partnership with top mid-career executives. a leading health care software company, in its acquisition by The Brydon Group.
Number of investments a year: Approx 10 Examples of previous investments: White Label Loyalty, Previsico, The Bunch, Beaconsoft and LightPoint Medical. Number of investments a year: 15 Examples of previous investments: Chargemaster, Ebury, Pod, PayasUgym, PowerX and Lightpoint Medical. Contact: john@advantagebusinessangels.co.uk
Based on the large number of medical practices acquired over the past decade, you may think selling your practice is a routine process. For them, finding a growth-focused partner who will contribute financial and human capital is the main objective. If you don’t think you can work together, it is best not to go any further.
He also started and helped lead a lower middle market privatecapital group focused on adding value alongside successful entrepreneurs. His work includes business sales and capital raises for middle-market companies as well as buy-side services for acquirers seeking middle-market companies.
By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success Angel investing is early-stage equity investment from high-net-worth individuals. It is a form of equity funding that precedes venture capital and privateequity. There are other differences, however.
As the Federal Reserve moves toward a more predictable and potentially lower rate trajectory, financing conditions are expected to improve, enabling both strategic buyers and privateequity investors to pursue transactions with greater confidence.
Summary Privateequity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once privateequity groups and lenders become comfortable with the interest rate environment.
Complex and novel transaction structures for the sector also were a prominent result of the market and regulatory environment, with reverse mergers remaining a fixture and stock-for-stock deals and take-private transactions led by privateequity sponsors entering the scene. What’s next?
John Prothrow and his investor friends put capital, energy, and professionalism behind the business. He put capital, energy, and professionalism behind the business, and he turned the dying brand into a thriving franchise. The brand also receives many medical referrals from podiatrists and other foot specialists.
Out of the Nordic countries, companies such as Novo Nordisk capitalized on massive revenue boosts from weight-loss medications (Wegovy and Ozempic) with multibillion-dollar acquisitions.
However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined privateequity sponsor buyers. trillion. [2]
Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years. intensity dealmaking, as life sciences companies sought to deploy capital and keep pace in an environment of record growth. In fact, COVID?19’s
Behavioral Health, Infusion, and Staffing firms top the list in BRGs survey Many lower middle market privateequity groups have revisited their investment priorities as we enter 2025, making room for new opportunities across healthcare verticals. ophthalmology and ENT). However, we expect fewer new platform formations in PPM.
PrivateEquity in Franchising – PE-backed franchises can be a red flag for some buyers, as corporate strategies may prioritize investor returns over franchisee success. Some are owned by privateequity firms, which can change the dynamics of the business, sometimes prioritizing investor returns over franchisee success.
In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e., Other large funds include Perceptive Advisors, RA Capital, and RTW.
In 2024, infusion therapy services reached the highest volume of deals to date, all of which were completed by privateequity investors. Privateequity investors see these new options as an attractive growth opportunity for an already thriving industry.
Meanwhile, privateequitys growing presence in the space is driving franchising and roll-ups, intensifying competition and forcing providers to adapt pricing models and find new ways to differentiate. But as student needs grow, schools will expand their role in overall student health.
Consumer retail privateequity is so diverse that it almost seems like a paradox. Depending on the firm, a consumer retail privateequity deal might consist of: A leveraged buyout of a struggling offline retailer. On the Job Recruiting Should You Go Shopping for Consumer Retail PrivateEquity Jobs?
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content